Search

September 14, 2017—The 2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction, developed in collaboration with the ACC, AHA, APHRS, ASA, EHRA, IDSA, LAHRS, PACES, and STS, is intended to help clinicians in their decision-making process for managing leads and builds on the 2009 Transvenous Lead Extraction: Heart Rhythm Society Expert Consensus on Facilities, Training, Indications, and Patient Management document. It provides practical clinical guidance in the broad field of lead management, including lead extraction.

The document features a clinician summary  (an educational derivative product of the full document) and a pocket card, developed in partnership with Guideline Central and available across multiple platforms, including print, electronic media, and the Guideline Central mobile app. Visit www.guidelinecentral.com  to access the pocket card.

November 2008 —This policy update revises the recommendations from the original statement published under the North American Society of Pacing and Electrophysiology (NASPE) in 2001. The current recommendations include revisions to criteria on billing and collection, assistance that should or should not be performed, and the proper supervision necessary.

August 15, 2016 - IHE is an initiative undertaken by healthcare professionals and industry to facilitate and strengthen the sharing of clinical data among health information technology (IT) systems. Systems developed in accordance with IHE communicate with one another more readily and completely, are easier to implement, and enable care providers to use information more effectively. 

January 2003—The provision of services accompanying technology-based electrophysiological-related interventions created an opportunity for health care professionals to specialize in the field of cardiac rhythm management. Known as allied professionals (APs), this diverse group of nurses, physician assistants, technologists, technicians, and engineers is dedicated to promoting excellence in the care of patients with cardiac rhythm disorders.

This document was reaffirmed on February 7, 2018, and will be formally assessed by February 2023.

August 2011—Genetic testing is increasingly important in determining potential cardiac conditions in patients and is used in clinical settings more than ever before. To ensure that physicians have up-to-date knowledge of the evolving role of genetic testing for sudden death predisposing, genetic heart diseases in cardiology, which can be lifesaving for some patients, the Heart Rhythm Society and the European Heart Rhythm Association have prepared HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies

This document was reaffirmed on April 11, 2018, and will be formally assessed by April 2023.